ALX Oncology Holdings Inc. (ALXO) Misses Q1 EPS by 6c

ALX Oncology Holdings Inc. (NASDAQ: ALXO) reported Q1 EPS of ($0.58), $0.06 worse than the analyst estimate of ($0.52).

For earnings history and earnings-related data on ALX Oncology Holdings Inc. (ALXO) click here.

You May Also Be Interested In

• S&P shares jump report of potential CapIQ spinout
• Needham on Medtronic, Inc. (MDT): 'We believe that MDT is in the early stages of a strong product cycle'
• Popular stocks with increasing option volume: MU SPCX INTC ORCL PFE PLTR SOFI PBR MSTR HOOD SNDK MRVL